Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - SEELOS THERAPEUTICS, INC.Financial_Report.xls
10-K - 10-K - SEELOS THERAPEUTICS, INC.v304648_10k.htm
EX-2.1 - EXHIBIT 2.1 - SEELOS THERAPEUTICS, INC.v304648_ex2-1.htm
EX-23.1 - EXHIBIT 23.1 - SEELOS THERAPEUTICS, INC.v304648_ex23-1.htm
EX-31.1 - EXHIBIT 31.1 - SEELOS THERAPEUTICS, INC.v304648_ex31-1.htm
EX-32.2 - EXHIBIT 32.2 - SEELOS THERAPEUTICS, INC.v304648_ex32-2.htm
EX-31.2 - EXHIBIT 31.2 - SEELOS THERAPEUTICS, INC.v304648_ex31-2.htm
EX-32.1 - EXHIBIT 32.1 - SEELOS THERAPEUTICS, INC.v304648_ex32-1.htm
EX-10.31 - EXHIBIT 10.31 - SEELOS THERAPEUTICS, INC.v304648_ex10-31.htm
EX-23.2 - EXHIBIT 23.2 - SEELOS THERAPEUTICS, INC.v304648_ex23-2.htm

Exhibit 21

 

SUBSIDIARIES OF APRICUS BIOSCIENCES, INC.

 

1. BQ Kits, Inc., incorporated in California on September 19, 2011.
   
2. Apricus Pharmaceuticals USA, Inc. (formerly Topotarget USA, Inc.), incorporated in Delaware on July 12, 2006 and acquired by the Company on December 29, 2011.
   
3. NexMed Holdings, Inc., incorporated in Delaware on February 28, 1997.
   
4. NexMed (U.S.A.), Inc., incorporated in Delaware on June 18, 1997.
   
5. NexMed International Limited, incorporated in the British Virgin Islands on August 2, 1996.